112190-09-7

Basic information

• Product Name: 2-chloro-4-methyl-6-phenylnicotinonitrile
• Synonyms: 2-chloro-4-methyl-6-phenylnicotinonitrile
• CAS NO: 112190-09-7
• Molecular Formula: C₁₃H₉ClN₂
• Molecular Weight: 228.67696
• Mol File: 112190-09-7.mol
• Article Data: 5

Chemical Properties

• Appearance: /
• CAS DataBase Reference: 2-chloro-4-methyl-6-phenylnicotinonitrile(CAS DataBase Reference)
• NIST Chemistry Reference: 2-chloro-4-methyl-6-phenylnicotinonitrile(112190-09-7)
• EPA Substance Registry System: 2-chloro-4-methyl-6-phenylnicotinonitrile(112190-09-7)

Safety Data

• Hazardous Substances Data: 112190-09-7(Hazardous Substances Data)

Upstream product

• 875-35-4 2,6-dichloro-4-methylnicotinonitrile 
• 98-80-6 phenylboronic acid 
• 4240-97-5 4-methyl-2-phenyl-1,2-dihydro-6-oxo-5-pyridine-carbonitrile 
• 93-91-4 1-phenylbutan-1,3-dione 

Downstream Products

• 27330-30-9 2-methoxy-4-methyl-6-phenyl-nicotinonitrile 
• 858120-09-9 4-methyl-6-phenyl-nicotinonitrile 

Relevant articles and documents

Preparation method and application of 5-aminobenzene[b][1,8]naphthyridine compound

The invention belongs to the field of pharmaceutical chemistry, and specifically provides a preparation method and application of a 5-aminobenzene[b][1,8]naphthyridine compound. The preparation methodis a route for synthesis of the 5-aminobenzene [b][1,8] naphthalidine compound by intramolecular cyclization of a molecule of a 4,6-2-disubstituted-2-Naryl-3nitrile compound catalyzed by trifluoro-methanesulfonic acid, more 5-aminobenzene[b][1,8]naphthalidine compounds can be prepared, and the prepared compounds show good antitumor activity in vitro.

EPHA4 RTK INHIBITORS FOR TREATMENT OF NEUROLOGICAL AND NEURODEGENERATIVE DISORDERS AND CANCER

The present invention is directed to compounds of generic formula (I) which are inhibitors of ephrin A4. The invention is also directed to pharmaceutical compositions comprising the compounds, and to the use of the compounds and compositions in the treatm

NOVEL PYRIDINE DERIVATIVES, A PROCESS FOR THEIR PREPARATION AND A PHARMACEUTICAL COMPOSITION CONTAINING THE SAME

This invention relates to novel pyridine derivatives having an inhibitory effect on production of cytokines, which are involved in inflammatory responses, thus suggesting its usefulness as therapeutic agents for treating diseases related to inflammation, immune, chronic inflammation as well as an agent having an anti-inflammatory and analgesic effect. Further, this invention relates to a method of manufacturing the same and a pharmaceutical composition containing the same.